A Scoping Review of Preclinical Paradigms for Clinically Tested Medications in Alcohol Use Disorder

Documenti analoghi

• Elevations in interleukin‐8 levels in individuals with alcohol use disorder and clinical insomnia symptoms
  di: Erica N. Grodin, et al.
  Pubblicazione: (2024)
• Medication effects on cue‐induced craving in the human laboratory are associated with return to heavy drinking in randomized clinical trials for alcohol use disorder: A follow‐up meta‐analysis
  di: Steven J. Nieto, et al.
  Pubblicazione: (2026)
• Embracing the complexity of alcohol's immunomodulatory effects: Commentary on Monnig, Lamb, Clark, and Monti—“Acute changes in immune biomarkers under low and moderate dose alcohol in light and heavy drinkers: A randomized, placebo‐controlled trial”
  di: Erica N. Grodin, et al.
  Pubblicazione: (2025)
• Predictors of Long‐Term Alcohol Use Disorder Treatment Receipt Among Middle‐Aged and Older Adults With Problematic Alcohol Use
  di: Silke Behrendt, et al.
  Pubblicazione: (2025)
• Inflammatory endotoxin challenge in individuals with alcohol use disorder and controls
  di: Kaitlin R. McManus, et al.
  Pubblicazione: (2025)